Cargando…

Clinical Evaluation of a Novel and Mobile Autism Risk Assessment

The Mobile Autism Risk Assessment (MARA) is a new, electronically administered, 7-question autism spectrum disorder (ASD) screen to triage those at highest risk for ASD. Children 16 months–17 years (N = 222) were screened during their first visit in a developmental-behavioral pediatric clinic. MARA...

Descripción completa

Detalles Bibliográficos
Autores principales: Duda, Marlena, Daniels, Jena, Wall, Dennis P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860199/
https://www.ncbi.nlm.nih.gov/pubmed/26873142
http://dx.doi.org/10.1007/s10803-016-2718-4
_version_ 1782431029427961856
author Duda, Marlena
Daniels, Jena
Wall, Dennis P.
author_facet Duda, Marlena
Daniels, Jena
Wall, Dennis P.
author_sort Duda, Marlena
collection PubMed
description The Mobile Autism Risk Assessment (MARA) is a new, electronically administered, 7-question autism spectrum disorder (ASD) screen to triage those at highest risk for ASD. Children 16 months–17 years (N = 222) were screened during their first visit in a developmental-behavioral pediatric clinic. MARA scores were compared to diagnosis from the clinical encounter. Participant median age was 5.8 years, 76.1 % were male, and most participants had an intelligence/developmental quotient score >85; 69 of the participants (31 %) received a clinical diagnosis of ASD. The sensitivity of the MARA in detecting ASD was 89.9 % [95 % CI = 82.7–97]; the specificity was 79.7 % [95 % CI = 73.4–86.1]. In a high-risk clinical setting, the MARA shows promise as a screen to distinguish ASD from other developmental/behavioral disorders.
format Online
Article
Text
id pubmed-4860199
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-48601992016-05-21 Clinical Evaluation of a Novel and Mobile Autism Risk Assessment Duda, Marlena Daniels, Jena Wall, Dennis P. J Autism Dev Disord Original Paper The Mobile Autism Risk Assessment (MARA) is a new, electronically administered, 7-question autism spectrum disorder (ASD) screen to triage those at highest risk for ASD. Children 16 months–17 years (N = 222) were screened during their first visit in a developmental-behavioral pediatric clinic. MARA scores were compared to diagnosis from the clinical encounter. Participant median age was 5.8 years, 76.1 % were male, and most participants had an intelligence/developmental quotient score >85; 69 of the participants (31 %) received a clinical diagnosis of ASD. The sensitivity of the MARA in detecting ASD was 89.9 % [95 % CI = 82.7–97]; the specificity was 79.7 % [95 % CI = 73.4–86.1]. In a high-risk clinical setting, the MARA shows promise as a screen to distinguish ASD from other developmental/behavioral disorders. Springer US 2016-02-12 2016 /pmc/articles/PMC4860199/ /pubmed/26873142 http://dx.doi.org/10.1007/s10803-016-2718-4 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Duda, Marlena
Daniels, Jena
Wall, Dennis P.
Clinical Evaluation of a Novel and Mobile Autism Risk Assessment
title Clinical Evaluation of a Novel and Mobile Autism Risk Assessment
title_full Clinical Evaluation of a Novel and Mobile Autism Risk Assessment
title_fullStr Clinical Evaluation of a Novel and Mobile Autism Risk Assessment
title_full_unstemmed Clinical Evaluation of a Novel and Mobile Autism Risk Assessment
title_short Clinical Evaluation of a Novel and Mobile Autism Risk Assessment
title_sort clinical evaluation of a novel and mobile autism risk assessment
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860199/
https://www.ncbi.nlm.nih.gov/pubmed/26873142
http://dx.doi.org/10.1007/s10803-016-2718-4
work_keys_str_mv AT dudamarlena clinicalevaluationofanovelandmobileautismriskassessment
AT danielsjena clinicalevaluationofanovelandmobileautismriskassessment
AT walldennisp clinicalevaluationofanovelandmobileautismriskassessment